{"id":9888,"date":"2017-10-31T13:00:00","date_gmt":"2017-10-31T13:00:00","guid":{"rendered":"https:\/\/heliospectra.com\/blog\/mfn_news\/medical-420-doo-invests-in-heliospectra-led-solutions-2\/"},"modified":"2017-10-31T13:00:00","modified_gmt":"2017-10-31T13:00:00","slug":"medical-420-doo-invests-in-heliospectra-led-solutions-2","status":"publish","type":"mfn_news","link":"https:\/\/heliospectra.com\/nl\/blog\/mfn_news\/medical-420-doo-invests-in-heliospectra-led-solutions-2\/","title":{"rendered":"Medical 420 DOO Invests in Heliospectra LED Solutions"},"content":{"rendered":"
Indoor Cultivation Facility in Macedonia Will Use Swedish LED Grow Light Technology to Accelerate Harvest and Deliver Medicinal-Grade Cannabis<\/p>\n

Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces an order from Medical 420 a medicinal cannabis cultivation facility in Macedonia. The indoor controlled environment facility is investing in Heliospectra LED lighting solutions to improve quality, accelerate harvest cycles and increase yields. The order is valued at $117,000 USD (984,000 SEK).<\/strong><\/div>\n

“We are committed to growing the highest-grade flower and distilling the highest-grade concentrates in order to deliver consistent medical products and treatments to patients. Heliospectra has proven that they offer a robust solution with market-leading light quality and uniform distribution. This allows us to standardize highest quality while increasing yields,” said Tony Gasovski, owner and founder of Medical 420.<\/p>\n

The Republic of Macedonia legalized the use of cannabis for medical purposes in 2016, following European countries such as the Netherlands, Czech Republic and Portugal. Unlike most EU countries, production will not be carried out by a state monopoly, which has opened up the market as a potential production base for numerous companies, both local and international. <\/p>\n

Medical 420 is setting up a brand new vertical cultivation facility in Macedonia, and has chosen Heliospectra’s intense E60 series as sole-source lighting. The E60 is a fixed spectrum, high intensity LED grow light fixture developed together with some of the world’s leading commercial growers. The lamp has an optimized spectrum and its plug-and-play nature provides instant, high-quality light for horticulture crop production year round.<\/p>\n

“Heliospectra’s proven solutions deliver superior performance and durability while also achieving business advantages for growers and producers in the global marketplace. The ability to accelerate harvest while increasing yields and improving the quality of crops provides growers like Medical 420 with reliable, repeatable production forecasts and the opportunity to negotiate premium placement in the marketplace,” said Ali Ahmadian, Heliospectra, CEO. <\/p>\n

De oplevering vindt plaats en zal zichtbaar zijn in de rekeningen in Q4.<\/span><\/p>\n

\n

Investeerdersrelaties van Heliospectra:<\/strong><\/p>\n

Ali Ahmadian, CEO van Heliospectra | +46 (0)72 203 6344 |<\/span><\/p>\n

Ali.Ahmadian@heliospectra.com<\/span><\/a><\/p>\n

Redeye is Heliospectra Certified Advisor voor Nasdaq First North.<\/span> <\/span>www.redeye.se<\/span><\/a><\/p>\n

http:\/\/www.heliospectra.com<\/a><\/span><\/p>\n<\/div>\n

\n

Over Heliospectra<\/strong><\/p>\n

Heliospectra AB (publ) (OTCQB: HLS, FIRST NORTH: HELIO) is the industry’s most proven intelligent lighting technology for greenhouse and controlled plant growth environments. With the vision to make commercial crop production more connected and resource-efficient, growers and commercial producers across six continents use Heliospectra’s holistic and flexible solutions to consistently increase yields while producing crops that achieve quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Founded in 2006 and winner of multiple international awards and recognitions, Heliospectra has raised more than $32 million in capital to date. As a publicly traded company, the majority ownership remains with some of Heliospectra earliest investors Weland Staal<\/a>, <\/a>Midroc Nieuwe Technologie<\/a> en Zweeds Industrieel Fonds<\/a>. Ga voor meer informatie naar https:\/\/www.heliospectra.com<\/a>.<\/p>\n

Toekomstgerichte verklaringen<\/strong><\/p>\n

De verklaringen in dit persbericht zijn toekomstgerichte verklaringen zoals bedoeld in de federale effectenwetgeving. Dergelijke verklaringen zijn gebaseerd op onze huidige overtuigingen en verwachtingen en zijn inherent onderhevig aan belangrijke zakelijke, economische en concurrerende onzekerheden en onvoorziene omstandigheden, waarvan vele buiten onze macht liggen. Daarnaast zijn dergelijke toekomstgerichte uitspraken onderhevig aan aannames met betrekking tot toekomstige bedrijfsstrategie\u00ebn en beslissingen die aan verandering onderhevig zijn. Potenti\u00eble risico's en onzekerheden omvatten, maar zijn niet beperkt tot, technische vooruitgang in de sector en politieke en economische omstandigheden in de sector. We nemen geen verplichting op ons om toekomstgerichte uitspraken bij te werken om gebeurtenissen of ontwikkelingen weer te geven nadat een toekomstgerichte uitspraak is gedaan.<\/p>\n

This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14.00 CET \/ 6 AM EST on October 31, 2017.<\/em><\/p>\n<\/div>\n

\n

Bijlagen<\/strong>
Vrijgave<\/a><\/p>\n<\/div>\n